This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, H G Articles by Moran, E Search for Related Content PubMed PubMed Citation Articles by Wang, H G Articles by Moran, E

The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300.

Cold Spring Harbor Laboratory, New York 11724-2206.

ABSTRACT

The cell growth-regulating properties of the adenovirus type 5 (Ad5) E1A oncogene correlate closely with the binding of the E1A products to specific cellular proteins. These proteins include the products of the retinoblastoma tumor susceptibility gene and a 300-kDa product, p300. pRB binds to E1A sequences that are highly conserved among the E1A products of various serotypes, while p300 binding requires sequences in the E1A amino terminus, a region that is not highly conserved. To help evaluate the roles of the E1A-associated proteins in cell growth control, we have compared the p300-binding abilities of the E1A products of Ad5 and of the more oncogenic Ad12 serotype. We show here that despite encoding a sequence that varies somewhat from the p300-binding sequences of Ad5 E1A, the Ad12 E1A products associate with p300 with an affinity similar to that of the Ad5 E1A products. Both the 12S and 13S splice products of Ad12 E1A, like those of Ad5 E1A, encode proteins able to associate with p300. Interestingly, though, both also give rise to prominent forms that are amino terminally modified and unable to associate with p300. This modification, at least in the 13S product, does not appear to diminish the affinity of this product for the retinoblastoma protein.

This article has been cited by other articles:

• Napolitano, M. A., Cipollaro, M., Cascino, A., Melone, M. A. B., Giordano, A., Galderisi, U. (2007). Brg1 chromatin remodeling factor is involved in cell growth arrest, apoptosis and senescence of rat mesenchymal stem cells. J. Cell Sci. 120: 2904-2911 [Abstract] [Full Text]  
• Dryer, R. L., Covey, L. R. (2005). A Novel NF-{kappa}B-Regulated Site within the Human I{gamma}1 Promoter Requires p300 for Optimal Transcriptional Activity. J. Immunol. 175: 4499-4507 [Abstract] [Full Text]  
• Boulon, S., Dantonel, J.-C., Binet, V., Vie, A., Blanchard, J.-M., Hipskind, R. A., Philips, A. (2002). Oct-1 Potentiates CREB-Driven Cyclin D1 Promoter Activation via a Phospho-CREB- and CREB Binding Protein-Independent Mechanism. Mol. Cell. Biol. 22: 7769-7779 [Abstract] [Full Text]  
• Jayachandra, S., Low, K. G., Thlick, A.-E., Yu, J., Ling, P. D., Chang, Y., Moore, P. S. (1999). Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors. Proc. Natl. Acad. Sci. USA 96: 11566-11571 [Abstract] [Full Text]  
• Kao, C.-Y., Tanimoto, A., Arima, N., Sasaguri, Y., Padmanabhan, R. (1999). Transactivation of the Human cdc2 Promoter by Adenovirus E1A. E1A INDUCES THE EXPRESSION AND ASSEMBLY OF A HETEROMERIC COMPLEX CONSISTING OF THE CCAAT BOX BINDING FACTOR, CBF/NF-Y, AND A 110-kDa DNA-BINDING PROTEIN. J. Biol. Chem. 274: 23043-23051 [Abstract] [Full Text]  
• Kushner, D. B., Ricciardi, R. P. (1999). Reduced Phosphorylation of p50 Is Responsible for Diminished NF-kappa B Binding to the Major Histocompatibility Complex Class I Enhancer in Adenovirus Type 12-Transformed Cells. Mol. Cell. Biol. 19: 2169-2179 [Abstract] [Full Text]